Lotus Pharmaceutical Co Ltd
TWSE:1795
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Lotus Pharmaceutical Co Ltd (1795) under the Base Case is 353.49 TWD per share.
Compared with the current market price of 141.5 TWD, the stock appears
Undervalued by 60% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 54% in 2026 and about 18% a year on average over the next five years, above its five-year pace of 14%. If revenue grew at its five-year pace of 14%, the estimate would be about NT$423.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Lotus Pharmaceutical Does
Lotus Pharmaceutical is a drug maker based in Taiwan that develops, manufactures, and sells prescription medicines, mainly generic and specialty drugs. Its portfolio includes products such as oncology treatments, hormones, and other hard-to-make medicines that are sold to hospitals, pharmacies, distributors, and healthcare partners in Asia and other export markets.
- Headquarters
- Taiwan TW
- IPO date
- Dec 13, 2004
Revenue & Expenses Breakdown
Lotus Pharmaceutical Co Ltd
Earnings Waterfall
Lotus Pharmaceutical Co Ltd
Continue Research
Decided on Lotus Pharmaceutical? Get an email when Lotus Pharmaceutical Co Ltd reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one Lotus Pharmaceutical Co Ltd stock?
The intrinsic value for
Lotus Pharmaceutical Co Ltd (1795) under the Base Case is 353.49 TWD.
Is Lotus Pharmaceutical Co Ltd stock undervalued or overvalued?
Compared with the current market price of 141.5 TWD, the stock appears Undervalued by 60% .